Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cannon

Showing results (501-510 of 1,137) with videos related to

Pageof 114
Sort By:
European Heart Journal|July 19, 2006
Angiographically evident thrombus following fibrinolytic therapy is associated with impaired myocardial perfusion in STEMI: a CLARITY-TIMI 28 substudyAjay J Kirtane, Jonathan J Vafai, Sabina A Murphy, et al.
The American Journal of Cardiology|June 1, 1997
Management of unstable angina pectoris and non-Q-wave acute myocardial infarction in the United States and Canada (the TIMI III Registry)H V Anderson, R S Gibson, P H Stone, et al.
Journal of the American College of Cardiology|October 18, 2005
Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trialKausik K Ray, Christopher P Cannon, Carolyn H McCabe, et al.
Vascular Medicine (London, England)|January 27, 2025
Early combination lipid-lowering therapy is associated with greater achievement of goal LDL-C: Insights from the OPTIMIZE PAD-1 trialConnie N Hess, Ashley Daffron, Mark R Nehler, et al.
International Journal of Cardiology|May 13, 2018
Retraction notice to Addition or removal of guideline directed medical therapy in ambulatory patients with heart failure with reduced ejection fraction relative to change in symptom severity: An analysis from the PINNACLE (Practice Innovation and Clinical Excellence) Registry® [International Journal of Cardiology 254 (2018) 222-223]Nasrien E Ibrahim, Yang Song, Christopher P Cannon, et al.
European Heart Journal|October 18, 2003
Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE)M Moscucci, K A A Fox, Christopher P Cannon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Rapid in vivo monitoring of chemotherapeutic response using weighted sodium magnetic resonance imagingR P Kline, E X Wu, D P Petrylak, et al.
American Heart Journal|April 26, 2001
Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhageR P Giugliano, C H McCabe, E M Antman, et al.
Journal of Thrombosis and Thrombolysis|April 15, 2000
The Open Artery Hypothesis: Past, Present, and FutureM Goel, J T Dodge, M Rizzo, et al.
Platelets|July 29, 2009
Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations in P2RY12, P2RY1, and ITGB3Robert F Storey, S Melissa Thornton, Rachael Lawrance, et al.
Pageof 114

Showing results (501-510 of 1,137) with videos related to

Sort By:
Pageof 114
European Heart Journal|July 19, 2006
Angiographically evident thrombus following fibrinolytic therapy is associated with impaired myocardial perfusion in STEMI: a CLARITY-TIMI 28 substudyAjay J Kirtane, Jonathan J Vafai, Sabina A Murphy, et al.
The American Journal of Cardiology|June 1, 1997
Management of unstable angina pectoris and non-Q-wave acute myocardial infarction in the United States and Canada (the TIMI III Registry)H V Anderson, R S Gibson, P H Stone, et al.
Journal of the American College of Cardiology|October 18, 2005
Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trialKausik K Ray, Christopher P Cannon, Carolyn H McCabe, et al.
Vascular Medicine (London, England)|January 27, 2025
Early combination lipid-lowering therapy is associated with greater achievement of goal LDL-C: Insights from the OPTIMIZE PAD-1 trialConnie N Hess, Ashley Daffron, Mark R Nehler, et al.
International Journal of Cardiology|May 13, 2018
Retraction notice to Addition or removal of guideline directed medical therapy in ambulatory patients with heart failure with reduced ejection fraction relative to change in symptom severity: An analysis from the PINNACLE (Practice Innovation and Clinical Excellence) Registry® [International Journal of Cardiology 254 (2018) 222-223]Nasrien E Ibrahim, Yang Song, Christopher P Cannon, et al.
European Heart Journal|October 18, 2003
Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE)M Moscucci, K A A Fox, Christopher P Cannon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Rapid in vivo monitoring of chemotherapeutic response using weighted sodium magnetic resonance imagingR P Kline, E X Wu, D P Petrylak, et al.
American Heart Journal|April 26, 2001
Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhageR P Giugliano, C H McCabe, E M Antman, et al.
Journal of Thrombosis and Thrombolysis|April 15, 2000
The Open Artery Hypothesis: Past, Present, and FutureM Goel, J T Dodge, M Rizzo, et al.
Platelets|July 29, 2009
Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations in P2RY12, P2RY1, and ITGB3Robert F Storey, S Melissa Thornton, Rachael Lawrance, et al.
Pageof 114